What Does BPC-157 Do?

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from human gastric juice that has demonstrated significant tissue-healing, cytoprotective, and anti-inflammatory properties across hundreds of preclinical studies. It is one of the most extensively researched peptides in regenerative medicine.

How BPC-157 Works

BPC-157 operates through multiple mechanisms. Research shows it upregulates growth factor expression, including VEGF (vascular endothelial growth factor) and EGF (epidermal growth factor), which promote blood vessel formation and tissue repair. It also modulates the nitric oxide (NO) system, which plays a central role in inflammation and vascular function.

In preclinical models, BPC-157 has accelerated healing in tendons, ligaments, muscles, the gastrointestinal tract, and even bone. A 2018 study published in Current Pharmaceutical Design reviewed its effects across multiple organ systems, confirming its broad cytoprotective profile (PMID: 29569985).

Key Areas of Research

The peptide has been studied for gut protection (including NSAID-induced lesions and inflammatory bowel conditions), tendon and ligament repair, neuroprotection, and wound healing. A notable 2021 study demonstrated BPC-157’s ability to counteract organ damage in rat models, reinforcing its systemic protective effects (PMID: 34697268).

Importantly, BPC-157 has shown a favorable safety profile across all published preclinical studies, with no reported toxic doses — a rarity among bioactive peptides.

Related Resources

• BPC-157: Complete Research Guide — full mechanism of action, study summaries, and dosing protocols
• BPC-157 Product Page
• How to Reconstitute Peptides

---

Written by NorthPeptide Research Team · For laboratory and research use only. Not for human consumption. This article summarizes published preclinical research and does not constitute medical advice.

Written by NorthPeptide Research Team